Iradimed (IRMD) EBT Margin (2013 - 2026)

Iradimed (IRMD) has 14 years of EBT Margin data on file, last reported at 35.35% in Q1 2026.

• On a quarterly basis, EBT Margin rose 488.0% year-over-year to 35.35% in Q1 2026; TTM through Mar 2026 was 34.98%, a 175.0% increase from a year earlier, with the FY2025 full-year figure at 33.84%, up 69.0% from the prior year.
• EBT Margin for Q1 2026 stood at 35.35%, up from 34.33% in the prior quarter.
• Over the last five years, EBT Margin for IRMD reached as high as 38.83% in Q3 2023 and fell as low as 24.86% in Q1 2022.
• Historically, EBT Margin has averaged 32.72% across 5 years, with a median of 32.85% in 2023.
• Across the five-year window, EBT Margin jumped 1392 bps in 2022 and sank 381 bps in 2024, its largest moves.
• Year by year, EBT Margin stood at 31.64% in 2022, then climbed by 3 bps to 32.56% in 2023, then grew by 1 bps to 32.72% in 2024, then advanced by 5 bps to 34.33% in 2025, then advanced by 3 bps to 35.35% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 35.35% in Q1 2026, 34.33% in Q4 2025, and 34.42% in Q3 2025.